Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats
出版年份 2016 全文链接
标题
Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats
作者
关键词
-
出版物
TOXICOLOGY MECHANISMS AND METHODS
Volume 26, Issue 9, Pages 700-708
出版商
Informa UK Limited
发表日期
2016-10-27
DOI
10.1080/15376516.2016.1236425
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An initial phase of JNK activation inhibits cell death early in the endoplasmic reticulum stress response
- (2016) Max Brown et al. JOURNAL OF CELL SCIENCE
- Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats
- (2016) Naif O. Al-Harbi TOXICOLOGY MECHANISMS AND METHODS
- Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats
- (2016) Naif O. Al-Harbi TOXICOLOGY MECHANISMS AND METHODS
- Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress
- (2015) Faisal Imam et al. Cardiovascular Toxicology
- Histamine 4 receptor promotes expression of costimulatory B7.1/B7.2 molecules, CD28 signaling and cytokine production in stress-induced immune responses
- (2015) Sheikh Fayaz Ahmad et al. JOURNAL OF NEUROIMMUNOLOGY
- Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-κB activation against LPS-induced acute lung injury in mice
- (2015) Faisal Imam et al. PHARMACOLOGICAL RESEARCH
- Riboflavin attenuates lipopolysaccharide-induced lung injury in rats
- (2015) Naif O. Al-Harbi et al. TOXICOLOGY MECHANISMS AND METHODS
- Riboflavin attenuates lipopolysaccharide-induced lung injury in rats
- (2015) Naif O. Al-Harbi et al. TOXICOLOGY MECHANISMS AND METHODS
- Case series discussion of cardiac and vascular events following carfilzomib treatment: possible mechanism, screening, and monitoring
- (2014) Ajai Chari et al. BMC CANCER
- Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma
- (2013) M. Wang et al. BLOOD
- U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
- (2013) T. M. Herndon et al. CLINICAL CANCER RESEARCH
- Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies
- (2013) D. Siegel et al. HAEMATOLOGICA
- Proteotoxicity and Cardiac Dysfunction — Alzheimer's Disease of the Heart?
- (2013) Monte S. Willis et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of aryl hydrocarbon receptor signaling pathway in cardiotoxicity of acute lead intoxication in vivo and in vitro rat model
- (2013) Mushtaq A. Ansari et al. TOXICOLOGY
- An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma
- (2012) R. Vij et al. BLOOD
- A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma
- (2012) D. S. Siegel et al. BLOOD
- Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)
- (2012) Roman Hájek et al. BMC CANCER
- Role of carfilzomib in the treatment of multiple myeloma
- (2012) Rashid Z Khan et al. Expert Review of Hematology
- Key roles of endothelin-1 and p38 MAPK in the regulation of atrial stretch response
- (2010) Risto Kerkelä et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation
- (2010) Daniela Impellizzeri et al. BIOCHEMICAL PHARMACOLOGY
- Role of nuclear factor κB in cardiovascular health and disease
- (2010) Kim van der Heiden et al. CLINICAL SCIENCE
- MAPK signalling in cellular metabolism: stress or wellness?
- (2010) Helmuth Gehart et al. EMBO REPORTS
- Protective effects of aliskiren in doxorubicin-induced acute cardiomyopathy in rats
- (2010) Azhar Rashikh et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Targeting Cyclic Nucleotide Phosphodiesterase in the Heart: Therapeutic Implications
- (2010) Clint L. Miller et al. Journal of Cardiovascular Translational Research
- Cardioprotective Effect of Ficus hispida Linn. on Cyclophosphamide Provoked Oxidative Myocardial Injury in a Rat Model
- (2009) T.S. Shanmugarajan et al. International Journal of Pharmacology
- The NF- B Family of Transcription Factors and Its Regulation
- (2009) A. Oeckinghaus et al. Cold Spring Harbor Perspectives in Biology
- Advances in Targeting IKK and IKK-Related Kinases for Cancer Therapy
- (2008) D.-F. Lee et al. CLINICAL CANCER RESEARCH
- Mechanisms of Myocyte Cytotoxicity Induced by the Multiple Receptor Tyrosine Kinase Inhibitor Sunitinib
- (2008) B. B. Hasinoff et al. MOLECULAR PHARMACOLOGY
- Phosphodiesterase inhibitors
- (2006) Victoria Boswell-Smith et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now